Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Revelation Biosciences Stock Price, Quotes and Forecasts | NASDAQ:REVB | Benzinga

Q: What sector and industry does Revelation Biosciences (REVB) operate in?

Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Revelation Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REVB.

Open	$3.04
Close	$3.08
Volume / Avg.	11.09K / 156.52K
Day Range	$2.94 - $3.12
52 Wk Range	2.36 - 60.80
Market Cap	$2.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	5.97%
Days to Cover	1

Recent News

Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Revelation Biosciences (REVB) Stock Is Down 38%

Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.

Henry Khederian

Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.04
Close	$3.08
Volume / Avg.	11.09K / 156.52K
Day Range	$2.94 - $3.12
52 Wk Range	2.36 - 60.80
Market Cap	$2.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	5.97%
Days to Cover	1

About Revelation Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing i...

Got Questions? Ask

How is REVB's revenue growing?

What is REVB's all-time low price?

What is REVB's current ratio?

What is REVB's dividend yield?

What’s driving REVB's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Revelation Biosciences (REVB) stock?

You can purchase shares of Revelation Biosciences (NASDAQ:REVB) through any online brokerage.

View our list of the best stock brokerages

Who are Revelation Biosciences (REVB) competitors?

Other companies in Revelation Biosciences’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO) and Synaptogenix (NASDAQ:SNPX).

What is the forecast, or price target, for Revelation Biosciences (REVB) stock?

Revelation Biosciences has a consensus price target of $15.00.

What is the current price for Revelation Biosciences (REVB)?

The stock price for Revelation Biosciences (NASDAQ: REVB) is $3.07 last updated April 17, 2025 at 4:49 AM EDT.

Does Revelation Biosciences (REVB) pay a dividend?

There are no upcoming dividends for Revelation Biosciences.

When is Revelation Biosciences (NASDAQ:REVB) reporting earnings?

Revelation Biosciences’s Q1 earnings are confirmed for Friday, May 9, 2025.

Is Revelation Biosciences (REVB) going to split?

There is no upcoming split for Revelation Biosciences.

What sector and industry does Revelation Biosciences (REVB) operate in?

Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Revelation Biosciences Stock Price, Quotes and Forecasts

Revelation Biosciences (REVB) Forecast